N/A
Manufactured by SpecGx LLC
8,892 FDA adverse event reports analyzed
Last updated: 2026-04-15
CLOMIPRAMINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by SpecGx LLC. The most commonly reported adverse reactions for CLOMIPRAMINE HYDROCHLORIDE include DRUG INTERACTION, SOMNOLENCE, FALL, OFF LABEL USE, TREMOR. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CLOMIPRAMINE HYDROCHLORIDE.
Out of 4,400 classified reports for CLOMIPRAMINE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.